Q2 2021 Iterum Therapeutics PLC Earnings Call Transcript
Hello, and welcome to Iterum Therapeutics Q2 Financial Results Conference Call. (Operator Instructions)
I now have the pleasure of handing over to Louise Barrett, Senior Vice President of Legal Affairs.
Thank you, Hannah. Good morning, and welcome to Interim Therapeutics Second Quarter 2021 Financial Results and Business Update Conference Call. A press release with the company's second quarter results was issued earlier this morning and can be found on our website.
We are joined this morning by Corey Fishman, CEO; and Judy Matthews, CFO. Corey will provide some opening remarks. Judy will provide details on our financial results, and then we'll open the floor for Q&A.
Before we begin, I'd like to remind you that this call will contain forward-looking statements concerning our plans, strategies and prospects for our business, including with respect to planned interactions and communications with the FDA following receipt of the Complete Response Letter
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |